Home DailyMed de4be028-c716-45a9-a821-ef71dec41f7b National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:54:31 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021506-002 MYCAMINE MICAFUNGIN SODIUM EQ 50MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-16 N021506-003 MYCAMINE MICAFUNGIN SODIUM EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2006-06-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021506-002 MYCAMINE EQ 50MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021506-003 MYCAMINE EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2006-06-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021506-002 MYCAMINE EQ 50MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2005-03-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021506-003 MYCAMINE EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INTRAVENOUS RLD 2006-06-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2006-06-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2005-03-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS RLD 2006-06-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021506-002 MYCAMINE EQ 50MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2005-03-16 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 MYCAMINE EQ 100MG BASE/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2006-06-27 74a2ff9319b5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 76 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 79 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021506-002 6107458 2019-03-16 U-845 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6107458 2019-03-16 U-650 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 U-650 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104 2021-01-08 U-845 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-002 6774104*PED 2021-07-08 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6107458 2019-03-16 U-845 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6107458 2019-03-16 U-650 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 Drug product 2013-06-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 U-650 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104 2021-01-08 U-845 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021506-003 6774104*PED 2021-07-08 Pediatric extension 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N021506-002 6774104 2021-01-08 U-650 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021506-002 6774104 2021-01-08 U-845 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021506-002 6774104*PED 2021-07-08 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021506-003 6774104 2021-01-08 U-845 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021506-003 6774104 2021-01-08 U-650 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021506-003 6774104*PED 2021-07-08 Pediatric extension 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021506-002 6774104 2021-01-08 U-650 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021506-002 6774104 2021-01-08 U-845 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021506-002 6774104*PED 2021-07-08 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021506-003 6774104 2021-01-08 U-845 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021506-003 6774104 2021-01-08 U-650 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021506-003 6774104*PED 2021-07-08 Pediatric extension 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021506-002 6774104 2021-01-08 U-650 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021506-002 6774104 2021-01-08 U-845 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021506-002 6774104*PED 2021-07-08 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021506-003 6774104 2021-01-08 U-845 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021506-003 6774104 2021-01-08 U-650 Drug product 5aa47cf7b7d7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 68 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.